Brief: Dermapharm Holding - Q1 Consolidated Revenue Up 1.1% Y/Y To EUR 305.8 Mln
May 13 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE: Q1 CONSOLIDATED REVENUE INCREASES BY 1.1% YEAR ON YEAR TO EUR 305.8 MILLION GROWTH IN ADJUSTED EBITDA OUTPACES REVENUE GROWTH BY 7.5%, CLIMBING TO EUR 87.4 MILLION ADJUSTED EBITDA MARGIN AMOUNTS TO 28.6% (+1.7 PERCENTAGE POINTS) CONFIRMS OUTLOOK FOR 2026 Further company coverage: DMPG.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit